1. RESEARCH SCOPE
    1. STUDY DELIVERABLES
    2. SCOPE OF THE STUDY MARKET AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    1. SOURCES OF DATA
    2. BOTTOM-UP APPROACH
    3. TOP-DOWN APPROACH
    4. DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
  4. MARKET OVERVIEW
    1. CRISPR TECHNOLOGY
    2. VALUE CHAIN ANALYSIS
    3. KEY BUYING CRITERIA
    4. STRATEGIC RECOMMENDATION AND CONCLUSION
    5. MERGERS AND ACQUISITION
  5. ANALYTICAL OVERVIEW
    1. GENE EDITING
  6. MARKET DETERMINANTS
    1. DRIVERS
    2. RESTRAINTS
    3. OPPORTUNITIES
    4. CHALLENGES
  7. MARKET SEGMENTATION
  8. BY PRODUCT
    1. GLOBAL CRISPR MARKET BY DESIGN TOOLS PRODUCT
    2. GLOBAL CRISPR MARKET BY PLASMIDS AND VECTORS PRODUCT
    3. GLOBAL CRISPR MARKET BY CAS9 NUCLEASE AND GRNA PRODUCT
    4. GLOBAL CRISPR MARKET BY DELIVERY SYSTEM PRODUCT
  9. BY END USER
    1. BIOTECHNOLOGY COMPANIES
    2. PHARMACEUTICAL COMPANIES
    3. ACADEMIC INSTITUTES
    4. RESEARCH AND DEVELOPMENT INSTITUTES
  10. GEOGRAPHICAL ANALYSIS
  11. NORTH AMERICA
    1. UNITED STATES
    2. CANADA
    3. RONA (REST OF NORTH AMERICA)
  12. EUROPE
    1. UNITED KINGDOM
    2. FRANCE
    3. GERMANY
    4. SPAIN
    5. ITALY
    6. ROE (REST OF EUROPE)
  13. APAC
    1. INDIA
    2. CHINA
    3. JAPAN
    4. SOUTH KOREA
    5. ROAPAC
  14. REST OF THE WORLD
  15. COMPETITIVE ANALYSIS
  16. COMPANY PROFILING
    1. EDITAS MEDICINE
    2. CRISPR THERAPEUTICS AG
    3. HORIZON DISCOVERY PLC.
    4. SIGMA-ALDRICH
    5. GENSCRIPT
    6. SANGAMO BIOSCIENCES, INC.
    7. LONZA GROUP AG
    8. INTEGRATED DNA TECHNOLOGIES (IDT)
    9. NEW ENGLAND BIOLABSINC,
    10. NOVARTIS
    11. ORIGENE TECHNOLOGIES INC,
    12. TRANSPOSAGEN BIOPHARMACEUTICALS
    13. THERMO FISHER SCIENTIFIC
    14. CARIBOU BIOSCIENCES, INC.
    15. PRECISIONBIOSCIENCES
    16. CELLECTIS
    17. INTELLIA THERAPEUTICS, INC

 

LIST OF TABLES
1. GLOBAL DNA SEQUENCING MARKET BY END-USER SEGMENT 2017-2025 ($ MILLIONS)
2. VARIOUS INITIATIVES AND POLICIES UNDERTAKEN BY THE GOVERNMENT IN HEALTHCARE SECTOR
3. RISING PUBLIC HEALTH AND LONG-TERM CARE EXPENDITURE OVER THE NEXT DECADES
4. MAJOR CONCERNS RELATED WITH THE GENETIC ENGINEERING
5. GLOBAL CRISPR MARKET BY PRODUCT MARKET SHARE 2017-2025 ($ MILLIONS)
6. TOOLS NAME AND THEIR PROVIDERS
7. GLOBAL CRISPR MARKET BY DESIGN TOOLS MARKET SHARE 2017-2025 ($ MILLIONS)
8. GLOBAL CRISPR MARKET BY PLASMIDS AND VECTORS MARKET SHARE 2017-2025 ($ MILLIONS)
9. GLOBAL CRISPR MARKET BY CAS9 NUCLEASE AND GRNA MARKET SHARE 2017-2025 ($ MILLIONS)
10. GLOBAL CRISPR MARKET BY DELIVERY SYSTEM MARKET SHARE 2017-2025 ($ MILLIONS)
11. GLOBAL CRISPR MARKET BY BIOTECH FIRMS 2017-2025 ($ MILLION)
12. GLOBAL CRISPR MARKET BY PHARMA COMPANIES 2017-2025 ($ MILLIONS)
13. LIST OF TOP UNIVERSITIES AROUND THE WORLD FOR GENETIC ENGINEERING, 2015
14. GLOBAL CRISPR MARKET BY RESEARCH FOUNDATION 2017-2025 ($ MILLIONS)
15. CRISPER MARKET, BY GEOGRAPHY 2017-2025 ($ MILLION)
16. EUROPE CRISPR MARKET 2017-2025 ($ MILLION)
17. APAC CRISPR MARKET 2017-2025 ($ MILLIONS)

 

LIST OF FIGURES
1. VALUE CHAIN ANALYSIS
2. CAUSES OF DEATHS DURING 2016, WORLDWIDE
3. FATALITIES INCREASING DUE TO LIFE STYLE ORIENTED DISEASES (IN THOUSAND)
4. REASON FOR OUTSOURCING DRUG DISCOVERY PROJECTS
5. GLOBAL CELL LINE DEVELOPMENT MARKET SHARE BY REGION, 2016
6. GLOBAL CRISPR MARKET BY DESIGN TOOLS MARKET SHARE 2017-2025 ($ MILLIONS)
7. GLOBAL CRISPR MARKET BY PLASMIDS AND VECTORS MARKET SHARE 2017-2025 ($ MILLIONS)
8. GLOBAL CRISPR MARKET BY CAS9 NUCLEASE AND GRNA MARKET SHARE 2017-2025 ($ MILLIONS)
9. GLOBAL CRISPR MARKET BY DELIVERY SYSTEM MARKET SHARE 2017-2025 ($ MILLIONS)
10. GLOBAL CRISPR MARKET BY END USER MARKET SHARE 2017-2025 ($ MILLIONS)
11. GLOBAL CRISPR MARKET BY BIOTECH FIRMS 2017-2025 ($ MILLION)
12. LEADING VENTURE CAPITAL FINANCED BIOTECHNOLOGY COMPANIES IN SWITZERLAND IN 2014 ($ MILLION)
13. GLOBAL CRISPR MARKET BY PHARMA COMPANIES 2017-2025 ($ MILLION)
14. GLOBAL CRISPR MARKET BY ACADEMIC INSTITUTIONS 2017-2025 ($ MILLION)
15. GLOBAL CRISPR MARKET BY ACADEMIC INSTITUTIONS 2017-2025 ($ MILLION)
16. GLOBAL CRISPR MARKET BY RESEARCH FOUNDATION 2017-2025 ($ MILLIONS)
17. NORTH AMERICA CRISPER MARKET 2017-2025 ($ MILLION)
18. ADOPTION OF GMO CROPS IN THE U.S. IN 2016
19. GLOBAL PHARMACEUTICAL MARKET REVENUE DISTRIBUTION BY REGION IN 2014
20. U.S. CRISPR MARKET 2017-2025 ($ MILLION)
21. REASONS FOR ADOPTING GENETICALLY ENGINEERED CROP (BT COTTON)
22. CANADA CRISPER MARKET 2017-2025 ($ MILLION)
23. RONA CRISPER MARKET 2017-2025($MILLION)
24. EUROPE CRISPR MARKET 2017-2025 ($ MILLION)
25. UK CRISPR market 2017-2025 ($ MILLION)
26. FRANCE CRISPR MARKET 2017-2025 ($ MILLION)
27. GERMANY CRISPR MARKET 2017-2025 ($ MILLION)
28. SPAIN CRISPR MARKET 2017-2025 ($ MILLION)
29. ITALY CRISPR MARKET 2017-2025 ($ MILLION)
30. REST OF EUROPE CRISPR MARKET 2017-2025 ($ MILLION)
31. INDIA CRISPR MARKET 2017-2025 ($ MILLION)
32. CHINA CRISPR MARKET 2017-2025 ($ MILLION)
33. JAPAN CRISPR MARKET 2017-2025 ($ MILLION)
34. SOUTH KOREA CRISPR MARKET 2017-2025 ($ MILLION)
35. ROPAC CRISPR MARKET 2017-2025 ($ MILLION)
36. ROPAC CRISPR MARKET 2017-2025 ($ MILLION)